shieldlegalcasesubmit

Time is Limited - Act Now

Time is Limited
Act Now

bard1

POPULAR DRUGS LINKED TO GASTRIC INJURIES—THOSE AFFECTED MAY BE ELIGIBLE FOR COMPENSATION.

To Qualify:

  • 75 or younger
  • Used Ozempic®, Wegovy®, or Rybelsus® brand names only
  • Diagnosis of gastroparesis, stomach paralysis, or gastric obstruction while taking the drug or within 30 days of stopping
  • Required emergency room visit or hospital admission

Those With Issues Following Using Ozempic®, Wegovy®, Saxenda®, Victoza®, Mounjaro®, or Rybelsus®

GLP-1 agonist medications, such as Ozempic®, Wegovy®, Mounjaro®, and others, prescribed for diabetes and losing pounds, have been associated with severe gastrointestinal illnesses and significant side effects, leading to potential hospitalization or permanent injury.

Numerous adverse event reports related to these drugs have been reported to the United States Food and Drug Administration (U.S. F.D.A.).

Possible side effects and complications include:

  1. Gastroparesis (stomach paralysis) leading to hospitalization
  2. Ileus diagnosis
  3. Pancreatitis diagnosis
  4. Bowel obstruction (blocked intestine) requiring hospitalization
  5. Pulmonary aspiration during anesthesia or surgery

Individuals who have taken GLP-1 medications like Ozempic®, Wegovy®, Saxenda®, Victoza®, Mounjaro®, or Rybelsus® and experienced severe side effects may be eligible for compensation.

iStock-1784044156-1

Which popular medications are currently under investigation?

Ozempic®, Mounjaro®, and other GLP-1 medications famous for helping to become more slim are currently under investigation by Seeger Weiss® for claims of serious side effects.

Serious side effects and complications associated with these medications include 

  • Gastroparesis (stomach paralysis);
  • Ileus;
  • Pancreatitis;
  • Bowel obstruction; and,
  • Pulmonary aspiration during surgery or anesthesia.

Medications linked to these serious disorders include:

  • Ozempic® (semaglutide)
  • Wegovy® (semaglutide)
  • Saxenda® (liraglutide)
  • Victoza® (liraglutide)
  • Mounjaro® (tirzepatide)
  • Rybelsus® (semaglutide)

Despite claims related to these products, the drugs/medical devices remain approved by the U.S. F.D.A.

If you have experienced such issues, you may be eligible for compensation.

Eligible victims are encouraged to request a free, private case evaluation by our experienced legal staff with the potential for compensation and justice.

Find Out if You Qualify

*Consent: By clicking the "SUBMIT" button, I consent to receive recurring auto dialed and/or text messages from Shield Legal Case Submit or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal Case Submit Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.

Those With Issues Following Using Ozempic®, Wegovy®, Saxenda®, Victoza®, Mounjaro®, or Rybelsus®

GLP-1 agonist medications, such as Ozempic®, Wegovy®, Mounjaro®, and others, prescribed for diabetes and losing pounds, have been associated with severe gastrointestinal illnesses and significant side effects, leading to potential hospitalization or permanent injury.

Numerous adverse event reports related to these drugs have been reported to the United States Food and Drug Administration (U.S. F.D.A.).

Possible side effects and complications include:

  1. Gastroparesis (stomach paralysis) leading to hospitalization
  2. Ileus diagnosis
  3. Pancreatitis diagnosis
  4. Bowel obstruction (blocked intestine) requiring hospitalization
  5. Pulmonary aspiration during anesthesia or surgery

Individuals who have taken GLP-1 medications like Ozempic®, Wegovy®, Saxenda®, Victoza®, Mounjaro®, or Rybelsus® and experienced severe side effects may be eligible for compensation.

iStock-1784044156-1

Which popular medications are currently under investigation?

Ozempic®, Mounjaro®, and other GLP-1 medications famous for helping to become more slim are currently under investigation by Seeger Weiss® for claims of serious side effects.

Serious side effects and complications associated with these medications include 

  • Gastroparesis (stomach paralysis);
  • Ileus;
  • Pancreatitis;
  • Bowel obstruction; and,
  • Pulmonary aspiration during surgery or anesthesia.

Medications linked to these serious disorders include:

  • Ozempic® (semaglutide)
  • Wegovy® (semaglutide)
  • Saxenda® (liraglutide)
  • Victoza® (liraglutide)
  • Mounjaro® (tirzepatide)
  • Rybelsus® (semaglutide)

Despite claims related to these products, the drugs/medical devices remain approved by the U.S. F.D.A.

If you have experienced such issues, you may be eligible for compensation.

Eligible victims are encouraged to request a free, private case evaluation by our experienced legal staff with the potential for compensation and justice.

100% Free & Secure Case Evaluations

Answer a few basic questions to get started

We'll ask specific questions to understand the situation, the injuries, and other vital info to help determine the next steps.

Receive a confidential case evaluation

A qualified legal team led by a personal injury attorney will consider the facts of the case and the potential for compensation.

Have an individual claim filed for compensation

Those that qualify will have an individual claim filed in a court of law for the justice and compensation they deserve.

Don’t suffer the severe side effects of these GLP-1 agonist medications in silence any longer—we fight for justice!

Victims of the severe side effects of these popular medications—and the families that suffered with them—should have every opportunity to receive the compensation and justice they deserve.

Please seek the advice of a medical professional before making health care decisions. This advertisement is not associated with any government agency.

www.shieldlegalcasesubmit.com is the property of Shield Legal LLC. 7180 Pollock Drive, 2nd Floor, Las Vegas, NV 89119

This website is not part of the Facebook website or Facebook, Inc. Additionally, this site is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, INC.

ATTORNEY ADVERTISING. This Website is not intended to provide medical advice. Consult your doctor or physician before starting or stopping any medication.
Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. are not an indication of future results. Every case is evaluated on its own facts and circumstances. Valuation depends on facts, injuries, jurisdiction, venue, witnesses, parties, and testimony, among other factors. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. Shield Legal Case Submit does not itself provide legal services. Cases will be referred to third party attorneys and law firms. Do not rely on this advertisement in making any medical decision. Please call your physician before making any medical decision, including altering your use of any drug. Court costs and case expenses may be the responsibility of the client. Not available in all states. This advertisement is not intended as a testimonial, endorsement or dramatization, and does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter, either expressed or implied. Anyone considering a lawyer should independently investigate the lawyers' credentials and ability, and not rely upon advertisements or self-proclaimed expertise. Only persons age 18 or older have permission to access our Service. Our Service does not address anyone under the age of 13("Children").

Privacy Policy | Terms and Conditions | CCPA Privacy Notice | Do Not Sell My Info

©2024 Shield Legal Case Submit. All Rights Reserved